human
sera
examin
immunoblot
antibodi
revers
transcriptas
human
hepat
b
viru
hbv
believ
encod
p
open
read
frame
porf
sera
patient
selflimit
n
acut
n
chronic
n
hepat
analys
one
sera
marker
prior
infect
two
sera
chronic
infect
patient
react
protein
synthes
e
coli
contain
middl
part
predict
polymeras
e
coli
fusion
protein
contain
overlap
differ
region
porf
use
local
antigen
domain
antibodi
bind
two
differ
domain
repres
middl
ctermin
region
porf
obtain
sera
chronic
infect
patient
find
indirect
evid
vivo
express
complet
hbv
polymeras
read
frame
ifna
arrest
human
fibroblast
mclntyre
gene
express
translat
viral
immedi
earli
ie
protein
possibl
suppress
normallength
viral
transcript
lipp
brandner
contrast
munoz
carrasco
maintain
hela
cell
ko
protein
virion
format
complet
ifna
resist
howev
demonstr
viral
ie
protein
translat
viru
strain
ko
mcintyr
ifna
sensit
human
fibroblast
hela
cell
though
significantli
less
latter
addit
found
hu
rec
tnfa
alon
synergist
combin
hu
rec
ifni
imped
hsvl
ie
protein
format
likewis
wherea
earli
gene
express
sensit
arrest
ifna
tnfa
plu
ifni
almost
resist
tnfa
alon
final
observ
tnfa
alon
combin
ifni
unabl
either
increas
acceler
cytopathiceffect
cellsprevi
infect
human
fibroblast
te
rubella
viru
vero
cell
treatment
peripher
blood
lymphocyt
pbl
healthydonor
purifiedhb
ag
resultedin
interferongamma
productionin
dose
dependentmann
pbl
werepurifi
ficollpaqu
adjust
x
cellsml
interferon
measur
highli
sensit
enzyrnimrnunoassay
proven
free
crossreact
nglml
hb
ag
peak
day
incub
result
unit
interferon
gamma
interferon
alpha
could
detect
supernat
time
incub
interferon
gamma
product
hbsag
regul
pge
sinc
coincub
pge
togeth
hbsag
yield
decreas
interferon
gamma
titer
whera
indomethacin
treatment
togeth
hbsag
result
unit
interferon
gamma
tnf
known
antivir
properti
similar
interferon
two
fold
elev
interferon
gamma
product
coincub
hbsag
despit
low
lcm
virusspecif
cytotox
cell
activ
lcm
viru
effici
elimin
spleen
acut
infect
mice
lehmanngrub
f
moskophidi
heinrichpettcinst
f
exp
virolog
u
immunologi
univ
hamburg
mechan
higher
organ
control
viru
infect
uncertain
accord
one
wide
accept
hypothesi
cytotox
lymphocyt
ctl
destroy
infect
cell
vivo
therebi
block
viru
replic
balbc
mous
lcm
virusspecif
ctl
restrict
sole
class
antigen
l
balbicderiv
mutant
l
alter
act
restrict
element
although
lcm
virusspecif
ctl
gener
mice
perfectli
capabl
elimin
viru
also
transfer
immun
cell
mutant
infect
balbc
mice
vice
versa
effici
acceler
viru
elimin
recipi
interpret
observ
mean
ctl
playa
central
rote
control
lcm
viru
mous
howev
lyse
virusinfect
cell
rather
releas
induc
releas
factor
inhibit
viru
replic
nearbi
cell
gener
monoclon
antibodi
q
bind
glycosyl
domain
hepat
b
viral
surfac
hbsag
bind
antibodi
inhibitit
chemic
crosslink
human
serum
albunim
normal
human
serum
natur
inhibitor
present
anim
sera
except
chimpanze
serum
low
titer
elut
gel
chromatographi
monomer
albumin
mask
vivo
either
partial
complet
depend
hbsag
titer
purifi
hbsag
contain
close
bound
albumin
vitro
bind
normal
human
serum
albumin
bind
glutaraldehyd
modifi
monomer
albumin
suggest
small
subtract
albumin
approx
pmolrnl
modifi
vivoin
way
bind
surfac
hepat
b
viru
transactiv
recent
demonstr
certain
pathogen
transform
virus
find
rais
question
whether
transactiv
mechan
implic
hbv
associ
malign
transform
experi
report
focus
hbx
gene
whose
function
still
unknown
hbx
gene
clone
express
sv
express
vector
well
control
hb
gene
promot
cotransfect
plasmid
contain
bacteri
cat
gene
express
either
viral
mmtv
htl
v
rsv
cellular
promot
thymidin
kinas
transactiv
demonstr
interestingli
singl
copi
hbv
dna
found
suffici
transactiv
cell
appropri
specif
could
show
hepatoma
ul
integr
hbv
dna
sequenc
connect
human
dna
sequenc
also
caus
transactiv
show
consider
stronger
transactiv
effect
hbx
gene
alon
therefor
conclud
posit
feedback
effect
x
promot
exert
hbx
gene
product
investig
demonstr
whether
mechan
describ
inde
involv
process
malign
transform
isol
characteris
dhbv
relat
hepat
b
virus
spreng
el
r
e
f
kaleta
han
max
planck
inst
f
biochemi
martinsri
insr
f
geflii
gelkrankheiten
giessen
far
avian
hepat
b
virus
detect
pekin
duck
two
isol
dhbv
clone
sequenc
aimof
studi
character
supposedli
hepatocarcinogen
dhbvisol
brown
spot
duck
china
ii
investig
whether
dhbv
relat
virus
exist
avian
speci
larg
number
sera
differ
avian
speci
test
dna
spot
hybridis
presenc
dhbv
relat
viral
dna
posit
signal
obtain
sera
chines
duck
german
gees
heron
sever
isol
clone
sequenc
host
rang
determin
infect
german
duck
gees
analysi
reveal
close
related
avian
hepadna
virus
deriv
duck
gees
indic
major
genet
differ
chines
dhbv
isol
could
explain
put
hepatocarcinogen
properti
dhbvfrom
gees
pekin
duck
show
speci
specif
sequenc
differ
infecti
avian
speci
contrast
heron
hepat
b
viru
sequenc
highli
diverg
dhbv
preliminari
result
suggest
viru
infecti
duck
gees
studi
character
duck
hepat
b
viru
dhbv
associ
polymeras
radziwil
g
valeri
bosch
univ
heidelberg
hepadna
viru
popen
read
frame
probabl
code
viru
associ
polymeras
howev
pframe
sequenc
specif
antisera
react
fullength
pframe
product
synthes
vitro
unabl
detect
authent
vivo
pprotein
virion
intracellular
viral
core
altern
enzymat
activ
use
monitor
character
viral
polymeras
condit
could
found
open
viral
core
permeabl
macromolecul
fulli
retain
polymeras
activ
restrict
enzym
digest
fragment
carryingth
protein
coval
bound
viral
minu
strand
remain
associ
open
core
label
endogen
reaction
viral
polymeras
accept
number
exogen
templat
tight
associ
endogen
templat
andor
core
unusu
properti
dhbv
polymeras
obtain
diagnost
reagent
detect
acquir
immunodefici
viru
hiv
exposur
express
viral
antigen
repres
gag
env
protein
vector
preferenti
use
construct
express
larg
quantiti
fuse
protein
e
coli
gene
anal
techn
plasmid
carri
e
coli
lac
promotor
portion
e
coli
lac
z
gene
stabl
fusion
protein
electrophoret
transfer
incub
hivantibodi
posit
human
sera
reactiv
band
compar
immunoblot
done
protein
gradient
purifi
virion
result
western
blot
fusion
protein
contain
epitop
gag
pl
env
least
sensit
convent
elisa
immunofluoresc
immunoblot
commerci
avail
elisatest
base
recombin
protein
sever
exampl
critic
sera
emphas
reliabl
western
blot
bacteri
express
protein
anti
hivl
found
drug
addict
male
femal
haemophiliac
use
l
montagni
establish
anti
elisa
assay
confirm
indirect
immunofluoresc
assay
westernblot
test
screen
drug
addict
one
show
anti
hivl
reaction
till
haernophiliac
screen
anti
two
anti
contain
sera
show
also
stain
present
nobodi
determin
kind
reaction
due
doubl
infect
patient
hivl
caus
immunolog
crossreact
anti
glycoprotein
detect
antibodi
hiv
ii
lav
ii
germanand
westafrican
patient
immunofluoresc
immunoblot
sc
h
z
h
yer
virol
abt
bernhardnochtinst
hamburg
hiv
ii
obtain
dr
l
montagni
cultiv
differ
tcelllin
cem
use
indirect
immunofluorescencetechniqu
crossreact
sera
patient
hiv
infect
hiv
ii
infect
cemcel
found
contrast
sera
hiv
ii
infect
show
strong
reaction
hiv
hiv
ii
antigen
specif
immun
reaction
control
crossabsorpt
techniqu
use
either
hiv
hiv
ii
infect
celllin
immunoblot
antihiv
ii
posit
sera
react
gagprotein
hiv
preliminari
result
sera
africa
germani
show
predominantli
african
peopl
involv
infect
sinc
solid
phase
peptid
synthesi
introduc
merrifield
method
establish
mani
laboratori
synthet
peptid
becom
widespread
use
natur
medic
scienc
particular
synthet
peptid
use
specif
antigen
diagnost
test
system
detect
antibodi
patient
sera
monospecif
monoclon
antisera
peptid
sequenc
rais
anim
system
use
character
identif
nativ
polypeptid
cellular
molecular
system
proven
great
valu
immunolog
test
system
chemic
method
synthesi
consider
improv
adapt
autom
system
allow
high
yield
respect
product
consecut
purif
step
howev
still
expens
time
consum
use
elisaor
ria
test
antibodi
product
peptid
need
coupl
plastic
protein
support
may
lead
destruct
secondari
structur
loss
antigen
avoid
problem
develop
system
sidechain
protect
group
remov
without
simultan
cleavag
synthes
peptid
polystyren
support
peptid
ebv
hivspecif
protein
synthes
use
sensit
elisa
test
screen
patient
sera
specif
antibodi
addit
carrierbound
peptid
shown
potent
antigen
rais
antibodi
immun
anim
studi
cellular
immun
respons
two
synthet
peptid
latent
membran
antigen
bnlfima
epstein
barr
viru
possibl
candid
lydma
lymphocyt
detect
membran
antigen
two
peptid
repres
amino
acid
express
cell
surfac
situat
interior
cell
five
ebvposit
person
react
well
lymphocyt
prolifer
assay
bnlfli
howev
ebvneg
individu
also
show
borderlin
reaction
surprisingli
peptid
show
strongli
antiprolif
effect
thu
sequenc
seem
playa
role
recognit
ebv
infect
lymphocyt
specif
tcell
although
unspecif
stimulatori
effect
sequenc
rule
biolog
signific
strong
inhibitori
effect
peptid
present
clear
recent
abl
show
surfac
densiti
class
hla
antigen
burkitt
lymphoma
bl
cell
reduc
comparison
ebvtransform
peripherallymphoblastoid
cell
line
patient
addit
qualit
differ
bl
lcl
cell
detect
paper
present
data
class
rna
cell
line
northern
blot
total
poli
rna
hla
class
edna
probe
reveal
one
hla
class
transcript
bl
well
lcl
cell
differ
size
transcript
bl
lcl
cell
detect
use
slotblot
analysi
total
poli
rna
hla
class
edna
probe
scan
autoradiogram
could
show
rna
data
confirm
previou
protein
data
express
hla
class
antigen
bl
cell
lower
lcl
cell
regul
occur
transciptionallevel
howev
effect
direct
viral
effect
also
detect
ebvneg
bl
cell
relev
phenomenon
failur
immun
surveil
patient
develop
burkitt
lymphoma
proven
experi
treatment
peripher
blood
lymphocyt
pbl
patient
chronic
activ
hepat
b
healthi
donor
result
increas
interferon
gamma
product
pbl
purifi
ficollpaqu
adjust
x
cellsm
interferon
measur
highli
sensit
enzymimmunoassay
addit
interferon
alpha
result
interferon
gamma
product
dose
depend
manner
maxim
interferon
gamma
activ
obtain
day
incub
uml
interferon
alpha
howev
interferon
level
exhibit
healthi
donor
observ
patient
coincub
antibodi
interferon
alpha
gamma
led
undetect
amount
interferon
supernat
taken
togeth
observ
remain
note
consid
use
interferon
alpha
therapi
chronic
activ
hepat
b
clone
human
tumor
necrosi
factor
shown
activ
natur
killer
cell
nk
dose
depend
manner
variou
system
vivo
natur
nk
cell
defin
pretreat
mice
nk
specif
antibodi
antiasialo
wherea
periton
exsud
cell
show
less
nk
activ
human
peripher
blood
cell
result
significantli
increas
cytotox
capac
due
nk
cell
howev
system
fail
detect
interferon
turn
tnf
treatment
thu
addit
inject
compound
yield
addit
amount
nk
activ
therefor
conclud
tnf
abl
exibit
immunmodulatori
capac
similari
interferon
henc
molecular
defin
homolog
compound
antigolgi
autoantibodi
recent
describ
human
patient
suffer
autoimmun
diseas
mice
bear
certain
tumor
studi
mous
system
demonstr
tumor
ifself
induc
antigolgi
autoantibodi
transmiss
agent
found
associ
progressormomsv
transform
serial
passag
vivo
report
character
caus
agent
show
possess
properti
characterist
lactat
dehydrogenas
elev
viru
ldv
morpholog
nonarbo
togavirus
capac
elev
plasma
ldh
level
restrict
replic
subpopul
murin
macrophag
probabl
la
subset
extrem
high
serurntitr
loll
idsolml
acut
phase
infect
lifelong
viraemia
natur
autoantigen
await
character
well
regul
induct
phase
autoimmun
respons
ref
cite
e
weiland
f
weiland
clin
expo
imm
andgal
fusion
protein
insert
part
hb
c
hb
hb
xread
frame
use
screen
human
serum
sampl
presenc
antibodi
direct
hbxprotein
result
studi
show
antibodi
hbxprotein
demonstr
westernblot
patient
anamnest
hbv
infect
furthermor
serum
sampl
patient
chronic
hbv
infect
serum
sampl
patient
acut
hbv
infect
hbxantibodi
could
demonstr
control
sera
antibodi
reactiv
viral
xprotein
found
one
case
examin
specif
antibodi
reactiv
immunoprecipit
competit
experi
perform
antibodi
reactiv
could
compet
bygalx
demonstr
specif
summari
data
indic
antibodi
hbxprotein
present
approx
hepat
bpatient
titer
risesar
found
alreadi
earli
cours
infect
prognosi
outcomeof
infectionhowevercan
conclud
presenc
hbxantibodi
cotransfect
clone
plasmidintegr
hbvor
dhbvdna
dimer
genom
neomycin
neo
resist
confer
plasmid
ncoresist
clone
contain
chromosom
integr
viral
dna
obtain
cell
cultur
media
cell
extract
test
viral
protein
radioimmunoassay
immunoblot
analys
secret
viru
particl
replic
intermedi
integr
und
extrachromosom
viral
dna
analys
southernblot
analys
five
cell
line
differ
express
pattern
viral
antigen
obtain
viru
productin
could
demonstr
two
clone
extrachromosom
supercoil
hbv
dna
serv
templat
synthesi
rna
pregenom
vivo
could
identifi
result
suggest
integr
viral
dna
serv
templat
vitro
none
clone
transfect
dhbv
dna
viru
product
could
demonstr
therefor
conceiv
intracellular
factor
contribut
host
cell
specif
hepadna
virus
use
cell
system
possibl
identifi
factor
elucid
mechan
gene
express
replic
detail
liang
xh
diagnost
relev
antibodi
x
protein
hepat
b
viru
hbv
subject
controversi
analys
hbsag
posit
serum
sampl
n
patient
hepatocellular
carcinoma
hcc
presenc
antix
antibodi
immunoblot
two
xfusion
protein
galx
serv
substrat
posit
reaction
fusion
protein
obtain
four
sera
examin
specif
reaction
confirm
competit
experi
low
fraction
antix
posit
sera
exclud
antix
antibodi
gener
marker
hcc
four
antix
posit
sera
antibodi
titer
xprotein
higher
one
nucleocapsid
antigen
one
case
antix
activ
detect
even
dilut
conceiv
high
antix
antibodi
titer
hcc
patient
relat
x
gene
express
tumor
tissu
littl
known
protein
encod
xopen
read
frame
human
hepat
b
viru
identifi
xrelat
protein
antibodi
recogn
xprotein
sever
express
plasmid
construct
allow
express
differ
part
xframe
e
colia
fusion
protein
elucid
antibodi
variou
xrelat
protein
sequenc
addit
xprotein
synthes
first
aug
xgene
sequenc
vitro
transcript
translat
use
result
xprotein
aa
use
assay
xspecif
antibodi
use
approach
xspecif
antibodi
detect
particular
sera
patient
primari
liver
carcinoma
also
sera
patient
hbvinduc
liver
cirrhosi
therefor
expect
sequenc
xopen
read
express
hbvlife
cycl
liver
specimen
hbvinfect
patient
screen
western
blot
presenc
xencod
protein
one
xspecif
antibodi
found
recogn
protein
molecular
weight
kd
protein
differ
size
one
expect
conventionallyexpress
xframe
kd
also
size
occurr
kd
protein
xantigen
detect
sever
primari
liver
carcinoma
moriarti
et
al
infect
liver
primari
livercarcinoma
weim
er
h
max
planck
inst
f
biochemi
martinsri
ln
studi
examin
whether
counterselect
viral
replic
core
gene
expressio
n
plc
tissu
woodchuck
similar
known
human
plc
tissu
express
whcag
pre
protein
test
antibodi
correspond
protein
express
e
coli
immunoblot
analys
molecular
form
viral
dna
integr
extrachromosom
methylatedand
unmethylar
analys
southern
blotand
restrict
enzym
digest
plc
tissu
littl
whcag
express
found
indic
also
infect
plc
tissu
whcag
express
often
abolish
although
less
frequent
human
plc
tissu
integr
extrachromosom
dna
often
found
methyl
may
contribut
core
gene
inactiv
contrast
whcag
expressionwa
alway
observ
chronic
infect
often
plc
tissu
plc
tissu
predomin
express
alter
express
pre
protein
plc
tissu
may
contribut
reduc
viremia
anim
mechan
lead
alter
pre
expressio
n
tissu
remain
determin
bhx
open
read
frame
orf
clone
base
express
vector
cotransfect
plasmid
express
cat
gene
control
earli
promot
result
indic
transactiv
product
bhx
genew
also
test
integr
hbv
dna
sequenc
clone
human
hepatoma
tissu
cotransfect
experi
plasmid
express
cat
gene
control
promot
ltr
htlv
mmtv
respect
transactiv
demonstr
clone
sequenc
hbx
orf
front
cat
orf
could
identifi
promot
signal
might
control
hbx
gene
express
infect
liver
cell
transactiv
effect
hbx
promot
observ
hbv
dna
integr
hbx
gene
cotranscrib
flank
cellular
sequenc
investig
necessari
clarifi
whether
transactiv
mechan
hbv
induc
oncogenesi
epidemiolog
studi
infect
hepatocyt
hepat
b
viru
hbv
known
enhanc
frequenc
develop
hepatocellular
carcinoma
date
evid
demonstr
particular
intramolecular
cisinflu
integr
hbv
dna
adjac
cellular
sequenc
therefor
consid
transregul
hbv
dna
altern
mechan
hbv
relat
tumorigenesi
describ
transactiv
function
hbv
dna
found
stimul
chloramphenicolacetyltransferas
cat
activ
cotransfect
clone
hbv
dna
transactiv
depend
express
sequenc
hbv
x
region
perform
even
singl
copi
hbv
dna
survey
differ
isol
promot
effect
hbv
dna
observ
transactiv
promot
hsv
tk
gene
ltr
rsv
htlvi
mmtv
light
result
like
transactiv
hbv
dna
also
perform
hbv
infect
hepatocyt
might
well
also
cellular
gene
import
transform
deregul
mechan
max
v
pettenkof
inst
univ
miinchen
inst
virolog
chin
nat
acad
scienc
hepat
b
epsteinbarr
viru
ebv
caus
chronic
activ
diseas
link
neoplasia
man
question
need
discuss
whether
prevent
primari
infect
practic
approach
control
sever
diseas
strategi
possibl
vaccin
depend
epidemiolog
situat
case
control
immunosuppress
prior
vaccin
virusfre
individu
would
requir
extrem
safe
product
vaccin
hepat
b
product
produc
yeast
alreadi
commerci
avail
use
ebv
approach
success
yeastspecif
glycosyl
pattern
destroy
viral
antigen
express
select
part
ebv
genom
mammalian
cell
obtain
product
good
yield
authent
antigen
possibl
use
product
also
requir
appropri
adjuv
area
high
natur
risk
tumor
develop
sever
area
africa
southeast
asia
southern
china
particular
accumul
risk
hepatocellular
carcinoma
nasopharyng
carcinoma
vaccin
caus
effect
longterm
imrnun
inexpens
simpl
safe
applic
would
requir
start
long
proven
safe
chines
vaccinia
strain
tientan
construct
recombin
vaccinia
strain
includ
ebv
membran
hepat
b
surfac
antigen
antigen
express
high
level
person
without
risk
n
antibodi
analysi
ig
sub
class
show
restrict
igg
found
hl
vseroposit
igg
blood
serum
igg
cerebrospin
fluid
igg
igg
antibodi
could
detect
respect
case
hiv
specif
iga
antibodi
could
detect
igm
antibodi
one
case
seroconvers
observ
hiv
specif
igm
could
also
found
cerebrospin
fluid
two
patient
incipi
cerebr
symptom
result
confirm
western
blot
techniqu
base
routin
laboratori
diagnosi
serum
antibodi
year
monthli
detect
rate
infect
amount
person
averag
relat
femal
male
person
chang
year
might
influenc
screen
programm
perform
femal
prostitut
found
seroposit
clinic
examin
hiv
infect
patient
admit
citi
hospit
offenbachfrg
reveal
strike
sign
aid
infect
person
belong
risk
group
decemb
first
case
infect
record
contain
human
endogen
retrovir
sequenc
relat
simian
sarcoma
associ
viru
ssav
nucleotid
sequenc
pol
region
show
presenc
kb
read
frame
distinctli
relat
carboxytermin
half
revers
transcriptas
murin
leukemia
viru
akv
region
also
includ
put
rnase
h
domain
amino
acid
ident
well
conserv
prolin
posit
point
high
degre
homolog
akv
pol
sequenc
moreov
protein
secondari
structur
calcul
sequenc
agre
highest
degre
structur
conserv
rnase
h
domain
structur
element
found
region
also
seem
conserv
number
retrovir
rnase
h
domain
current
isol
cdna
clone
indic
sequenc
may
also
express
human
tissu
bullach
c
barnekoww
evalu
effect
cellular
infect
rou
sarcoma
viru
rsv
transform
oncogen
usrc
transcript
activ
protooncogen
test
cellular
oncogen
andactin
perform
nuclear
run
transcript
assay
use
nuclei
isol
rsv
infect
transform
chick
embryo
cell
ceq
drastic
reduct
transcript
activ
cfgr
protooncogen
could
observ
rsv
infect
cec
compar
uninfect
cec
transcript
rate
cfosand
cmycwer
also
reduc
lesser
extent
experi
temperaturesensit
transformationdefect
mutant
rsv
conclud
alter
observ
caus
viral
infect
due
process
transform
determin
transform
condyl
follow
alter
alp
activ
comparison
uninfect
control
uptak
deposit
radiolabel
ca
similar
transform
control
condyl
contrast
autoradiograph
analysi
reveal
irregular
pattern
bone
matrix
miner
virustransform
tissu
similar
observ
histolog
data
indic
morpholog
alter
observ
virusinduc
osteosarcomagenesi
vitro
associ
alter
ca
uptak
alp
activ
howev
bone
matrix
miner
follow
irregular
pattern
transform
tissu
xiphophoru
melanoma
format
assign
classic
genet
find
express
cellular
oncogen
name
tu
tu
propos
neg
control
cellular
antioncogen
regulatori
gene
r
molecular
natur
tu
r
unknown
far
order
contribut
understand
molecular
biolog
basi
melonoma
format
attempt
isol
character
oncogen
tu
identifi
restrict
fragment
length
polymorph
associ
tu
addit
analyz
structur
express
known
protooncogen
variou
mutant
xiphophoru
affect
melanoma
format
embryogenesi
csrc
era
express
peak
organogenesi
csi
express
elev
later
suggest
function
relat
cellular
differenti
prolifer
adult
era
express
tissu
specif
show
overexpress
tumor
tissu
era
csrc
cmycdemonstr
enhanc
express
melanoma
cerb
b
csi
express
tumor
cell
data
suggest
coordin
deregul
sever
oncogen
process
melanoma
format
andor
progress
serumdepriv
psm
melanoma
cell
lead
fold
elev
level
cerb
b
csrc
era
mrna
normal
level
restor
within
h
stimul
serumdepriv
embryon
cell
result
total
loss
cone
gene
express
without
reconstitut
h
demonstr
rhar
express
thesecon
gene
melanomacel
relat
prolifer
gener
may
instead
tumor
specif
featur
murin
leukemia
virus
mulv
isol
normal
irradi
bone
tissu
spontan
benign
malign
bone
tumor
radiationinduc
osteosarcoma
well
endogen
ecocrop
leukemia
viru
akr
mous
akv
previous
report
nononcogen
capabl
induc
osteoma
osteopetrosi
togeth
malign
lymphoma
nmri
mice
latent
period
vari
month
histolog
examin
virusinduc
bone
tumor
show
mark
differ
size
cell
layer
periosteum
degre
crypt
format
miner
osseou
tissu
number
metabol
activeosreoblast
restrict
map
differ
viru
genom
show
great
similar
akv
differ
structur
glucocorticoid
regulatori
element
gre
enhanc
sequenc
ltr
region
latter
exhibit
distinct
effect
dexamethasoneinduc
cat
activ
cell
osteoblastcel
line
dexamethasoneinduc
cat
activ
correl
also
dexamethasoneinduc
increas
osteoblast
differenti
howev
differ
ltr
structur
could
yet
associ
either
bone
tumor
incid
differ
latent
period
observ
variou
viru
type
previous
shown
spong
first
organismin
phylogenesi
contain
ancestr
csrc
gene
genom
llbrari
spongilla
lacustri
prepar
screen
usrc
relat
sequenc
preliminari
sequenc
result
one
clone
indic
homolog
nucleotid
aminoacid
level
vsrc
gene
interestingli
hybrid
data
suggest
spong
csrc
gene
may
shorter
higher
eukaryot
virtu
intern
region
gene
miss
observ
consist
data
spong
src
protein
angelika
barnekow
per
comrn
show
smaller
csrc
protein
product
possibl
due
delet
region
protein
correspond
miss
dna
sequenc
hydra
first
organismin
phylogenesi
differenti
nerv
cell
use
srcrelat
clone
isol
hydra
genom
bank
studi
neuronspecif
express
csrc
basi
dna
hybrid
protooncogen
ye
first
detect
lower
chordat
genom
bank
kiphophoru
maculatu
isol
srcand
yesrel
clone
may
repres
earli
stage
srclye
gene
duplicationdiverg
process
bister
x
koenen
sippel
c
trachmann
ottowarburglab
maxplanckinst
f
molek
genetik
diooo
berlin
zentrum
f
molek
biologi
univ
heidelberg
previous
describ
genom
organ
nucleotid
sequenc
chicken
emil
gene
within
region
homolog
vmil
one
two
oncogen
highli
oncogen
avian
retroviru
isol
emil
edna
clone
screen
chicken
edna
librari
vmilspecif
probe
nucleotid
sequenc
analys
overlap
emil
edna
clone
reveal
presenc
singl
larg
open
read
frame
encod
acid
protein
calcul
molecular
weight
good
agreement
appar
molecular
weight
report
emilprotein
detect
cellular
extract
carboxyltermin
region
amino
acid
residu
correspond
vmil
encod
portion
gagmil
hybrid
protein
homolog
catalyt
domain
protein
kinas
aminotermin
region
emil
protein
contain
sequenc
motif
like
cystein
rich
domain
found
regulatori
domain
protein
kinas
certain
receptor
molecul
serumfre
tissu
cultur
supernat
ssvtransform
nonproduc
cell
show
growthstimul
activ
pdgflike
characterist
nih
nonestablish
mous
fibroblast
furthermor
tissu
cultur
supernat
show
transform
activ
shown
induc
anchorageindepend
growth
nrk
nonestablish
goat
fibroblast
fraction
supernat
gel
filtrat
activ
present
highmolecularweight
fraction
kd
growthstimul
transform
activ
fraction
larg
inhibit
antibodi
pdgf
ssvnp
cell
use
tissu
cultur
supernat
prepar
sdspagefollow
electroelut
also
find
highmolecularweight
kd
growthstimul
colonyinduc
activ
inhibit
specif
antibodi
suggest
activit
due
highli
glycosyl
pdgflike
molecul
releas
ssvtransform
cell
formerli
describ
ssv
transformationspecif
glycopeptid
ssvtrsgp
virolog
regul
eukaryot
gene
express
interact
protein
specif
signal
promot
sequenc
playa
decis
role
methyl
specif
promot
sequenc
caus
inactiv
eukaryot
promot
studi
inactiv
late
promot
adenoviru
type
dna
methyl
three
sequenc
posit
rel
one
cap
site
langner
et
al
pna
mechan
dna
methyl
interf
regulatori
function
late
promot
known
dnase
protect
analys
least
six
differ
promot
sequenc
identifi
bind
specif
host
protein
bind
protein
unmethyl
methyl
late
promot
sequenc
compar
use
gel
migrat
delay
assay
dnase
protect
footprint
analys
appar
protein
bind
detect
affect
late
promot
methyl
still
conceiv
function
promoterbound
host
factor
alter
three
sequenc
ate
methyl
support
deutsch
forschungsgemeinschaft
lichtenberg
ursula
christin
zock
w
doerfler
inst
genet
univ
koln
hamster
tumor
genom
equival
integr
one
integr
copi
prove
unstabl
lost
rearrang
upon
cell
line
unstabl
site
junction
dna
hamster
dna
clone
sequenc
analyz
similarli
preinsert
site
hamster
cell
analyz
left
terminu
dna
first
nucleotid
delet
distanc
nucleotid
left
junction
site
intern
dispers
fragment
dna
bp
insert
cellular
dna
left
nucleotid
cellular
nucleotid
follow
abut
sequenc
left
termin
sequenc
endogen
intracistern
particl
lap
genom
hamster
cell
detect
possibl
signific
close
vicin
lap
sequenc
insert
genom
transform
event
instabl
site
transcript
activ
region
known
preinsert
sequenc
environ
also
investig
transcript
activ
found
distanc
sever
nucleotid
insert
site
aid
bmft
bct
fond
der
chemischen
industri
inst
f
immunbiologi
univ
freiburg
stabil
overexpressio
n
cellular
protein
might
play
key
role
transform
stabil
might
facilit
complex
format
antigen
modul
regulatoryproteas
andor
posttransl
modif
phosphoryl
state
normal
transform
rat
fibroblast
investig
normal
cell
appear
singl
speci
high
turnov
phosphoryl
hardli
detect
transform
cell
stabl
second
form
appear
deriv
first
form
addit
phosphoryl
reveal
puls
chase
experi
phosphopeptideanalysi
cell
abort
infect
highli
phosphoryl
form
appear
two
day
postinfect
suggest
larg
antigen
induc
activ
protein
kinas
one
substrat
might
earli
event
transform
support
sfb
landesschwerpunkt
badenwiirttemberg
schlrmb
eck
r
w
deppert
univ
dept
biochemistri
ulm
analyz
subnuclear
distribut
larg
cours
lytic
infect
earli
time
post
infect
larget
presentmainli
nucleoplasm
cellular
chromatin
concomit
onset
viral
dna
replic
amount
nuclear
matrix
associ
larg
increas
drastic
cours
infect
amount
chromatin
nuclear
matrix
associ
larg
increas
steadili
parallel
increas
viral
dna
synthesi
biolog
signific
correl
corrobor
analysi
cell
infect
tsamut
restrict
temperatur
larg
fail
initi
viral
dna
replic
infect
cell
also
fail
associ
cellularchromatin
nuclear
matrix
block
viral
dna
synthesi
aphidicolin
abl
show
accumul
larg
nuclear
structur
result
bind
larg
viral
chromatin
reflect
associ
cellular
compon
chromatin
nuclear
matrix
fish
lymphocysti
diseas
viru
fldv
member
iridoviru
famili
caus
wide
distribut
diseas
pleuronect
character
papillomalik
lesion
thymidin
kinas
gene
tk
activ
report
two
member
famili
iridovirida
name
frog
viru
fldv
identif
tk
gene
loci
fldv
genom
perform
transform
tk
neg
tk
posit
cell
use
specif
viral
dna
sequenc
transfect
assay
calcium
phosphat
techniqu
dna
fragment
viral
genom
use
studi
obtain
defin
gene
librari
fldv
genom
contain
complet
viral
dna
sequenc
select
convert
cell
carri
condit
hat
select
procedur
result
experi
reveal
ecorl
fldv
dna
fragment
c
kbp
mu
abl
transform
tk
neg
tk
posit
cell
addit
experi
perform
use
subclon
ecorl
dna
fragment
c
reveal
dna
sequenc
kbp
map
coordin
fldv
genom
possess
transform
abil
indic
tk
gene
loci
locat
particular
region
determin
nucleotid
sequenc
interest
gene
progress
dfg
project
da
neutral
monoclon
antibodi
obtain
immun
infecti
polioviru
recogn
conform
depend
epitop
react
isol
polypeptid
recent
obtain
three
neutral
monoclon
antibodi
usingan
appropri
vitro
immun
system
spleen
cell
prime
vivo
purifi
vpl
antibodi
recogn
also
isol
vpl
antibodi
bind
site
locat
amino
acid
residu
vpl
use
one
antibodi
select
neutral
escap
mutant
mutant
isol
alter
reveal
isoelectr
focus
urea
neutral
monoclon
antibodi
recogn
conform
depend
epitop
could
neither
neutralizenor
bind
mutant
conclud
region
amino
acid
residu
also
involv
format
epitop
group
antibodi
probabl
part
discontinu
epitop
major
antigen
determin
footand
mouth
diseas
viru
locat
within
region
amino
acid
coat
protein
vpl
synthet
peptid
repres
region
protect
guinea
pig
againstvir
infect
immun
affin
chromatographi
use
synthet
peptid
elimin
neutralisingact
hyperimmun
serum
investig
antigen
determin
detail
neutralis
monoclon
antibodi
mcab
rais
complet
viru
synthet
peptidethes
mcabscould
dividedinto
neutralis
group
bindingsitesof
mcab
local
differ
method
eg
western
blot
elisa
competit
experi
group
mcab
bound
synthet
peptid
isol
viral
particl
bind
could
inhibit
complet
peptid
mcab
two
group
bound
complet
viral
particl
weakli
peptid
correl
differ
neutralis
pattern
primari
structur
coat
protein
nucleotid
sequenc
code
antibodi
bindingsit
determin
fmdv
strain
test
conclus
analysi
demonstr
mcab
first
two
group
recogn
overlap
sequenti
epitop
wherea
mcab
two
group
recogn
conform
epitop
support
find
escap
mutant
select
mcab
group
sequenc
result
obtain
show
amino
acid
exchang
antibodi
bind
site
case
mcab
recogn
sequenti
epitop
contrast
case
amino
acid
exchang
found
two
coat
protein
induc
neutralis
antibodi
fmdv
serv
model
system
structur
function
analys
translat
process
translat
initi
atyp
eucaryot
intern
start
site
approx
nucleotid
downstream
end
rna
shown
delet
insert
mutat
larg
part
call
non
code
region
affect
strongli
effici
translat
initi
hot
spot
region
mutagenesi
also
point
mutat
pyrimidinerich
stretch
bp
front
loth
aug
function
start
codon
evid
ribosom
bind
directli
initi
site
whole
non
code
region
mark
high
degre
secondari
structur
abil
bind
sever
cytoplasm
factor
help
protein
rna
bind
assay
tri
analys
factor
involv
process
use
clone
coxsackieviru
edna
enterovir
diagnost
reagent
situ
hybrid
assay
develop
detect
main
etiolog
agent
viral
heart
diseas
singl
hybrid
assay
includ
coxsacki
b
virus
well
echovirus
endomyocardi
biopsi
patient
clinic
suspect
myocard
dilat
cardiomyopathi
examin
togeth
myocardi
tissu
recipi
heart
patient
underw
heart
transplant
enterovir
infect
myocardi
cell
detect
patient
suspect
myocard
wella
patient
dilat
cardiomyopathi
includ
recipi
heart
posit
hybrid
patient
myocardi
diseas
consist
suspect
viral
heart
diseas
eg
coronari
heart
diseas
use
intern
control
group
show
neg
hybrid
import
observ
number
infect
myocardi
cell
correl
sever
clinic
symptom
interestingli
positivehybrid
enterovir
rna
also
obtain
late
biopsi
eg
month
onset
diseas
indic
persist
viru
human
myocardium
case
f
sudden
infant
death
sid
case
nearsid
male
one
die
tri
isol
viru
mean
age
month
six
infant
immun
oral
polio
vaccin
six
immun
vaccin
histori
known
follow
specimen
examin
lung
intestin
brain
heart
trachea
csf
spleen
isol
attempt
primari
monkey
kidney
cell
human
embryon
lung
fibroblast
hela
cell
specimen
case
examin
elisa
influenza
ab
parainfluenza
adenoand
rsantigen
neg
result
isol
polioviru
case
x
type
x
type
x
type
one
untyp
enteroviru
agent
detect
intestin
polioviru
isol
absenc
vaccin
histori
one
case
howev
polioviru
isol
lung
oral
polio
vaccin
done
month
prior
sid
adrian
th
u
wolf
r
wigand
dept
virolog
fac
med
univ
saarland
homburg
patient
isol
collect
period
year
mainli
europ
usa
belong
adenoviru
subgenera
f
dna
strain
analys
seven
restrict
endonucleas
strain
indistinguish
immunolog
test
show
differ
dna
fragment
pattern
name
genom
type
genom
type
strain
belong
subgenu
c
found
variabl
also
could
seenfor
subgenu
b
moder
differ
showedgenom
type
subgenu
subgenu
b
subgenu
subgenu
e
variat
locat
genom
found
distribut
randomli
great
differ
wereseenbetween
genom
typesand
correspond
prototyp
small
one
among
genom
type
point
common
ancestor
kraiss
andrea
quaiser
montenarh
dept
biochemistri
univ
ulm
analyz
complex
format
two
cell
lineson
overexpress
latter
case
find
elev
level
complex
addit
free
therefor
conclud
amount
complex
determin
amount
sucros
gradient
analysi
show
cell
limit
amount
free
tantigen
complex
exist
predominantli
high
oligomer
form
high
level
present
lower
molecular
weight
complex
also
found
free
tantigen
predominantli
found
low
oligomer
form
whereasfre
rapidli
form
high
oligom
assum
bindspreferenti
alreadi
oligomer
tantigen
present
high
concentr
also
bind
lower
molecular
weight
form
tantigen
max
v
pettenkof
lnst
univ
miinchen
hno
clinic
univ
diisseldorf
antigen
site
pb
vca
bmrfi
ea
bclfl
ea
clone
puc
plndu
plasmid
express
e
coli
fusion
nonfus
protein
protein
purifi
partial
precipit
ionexchang
chromatographi
thesepurifiedantigen
test
elisa
human
sera
resultswer
compar
immunofluoresc
test
abl
show
good
correl
antiv
igg
igm
igg
igm
elisa
well
antiea
iggin
ifand
igg
elisa
antiea
igm
test
low
valu
specif
iga
found
mostli
sera
show
borderlin
titer
antivca
antiea
studi
unmethyl
vitro
methyl
viral
promot
express
base
transient
express
assay
therefor
mandatori
fix
integr
form
methyl
unmethyl
viral
promot
conjunct
indic
gene
genom
mammalian
cell
test
level
express
hamster
cell
cotransfect
construct
plasmid
contain
promot
adenoviru
type
dna
cell
line
select
carri
intact
promot
construct
sequenc
rearrang
line
gener
transfect
unmethyl
dna
urn
line
express
cat
gene
line
gener
transfect
methyl
dna
line
express
cat
gene
line
express
weakli
linesexpress
catgen
strongli
cell
line
express
cat
gene
vari
extent
late
promot
becom
partli
complet
demethyl
contrast
cell
line
express
cat
gene
late
promot
remainedalmost
completelymethyl
factor
determin
degre
demethyl
transfect
methyl
construct
support
deutsch
forschungsgemeinschaft
open
read
frame
orf
papillomavirus
highli
conserv
code
major
capsid
protein
protein
carri
groupspecif
typespecif
antigen
determin
clone
bp
haeiiifrag
central
less
conserv
part
orf
human
papillomaviru
procaryot
express
vector
give
rise
agalfusi
protein
guineapig
antiserum
protein
test
antigen
differ
wart
biopsi
use
indirect
immunofluoresc
test
western
blot
detectedcapsid
protein
close
relat
antiserum
react
structur
antigen
hpvl
indic
central
part
reveal
antigen
common
virus
associ
epidermodysplasia
verruciformi
contrast
groupspecif
antigen
appear
encod
part
orf
hcinrichpettelnst
f
exp
virologi
u
immunologi
univ
hamburg
rabbit
igg
antibodi
specif
polioviru
type
mahoney
use
rais
antiidiotop
guineapigsthes
antibodi
react
specif
antipolioviru
igg
elisa
furthermor
bind
antiidiotop
antipolioviru
rabbit
igg
complet
inhibit
polioviru
suggest
antiidioryp
antibodiesrecogn
determin
antipolioviru
antibodi
whichar
relat
site
polioviru
bind
reduc
competit
observ
use
heterolog
antipolioviru
antibodi
rat
mice
antiidiorop
induc
immun
respons
rabbit
mice
specif
polioviru
antisera
recogn
polioviru
elisa
differ
degre
howev
neutral
viru
therefor
conclud
antiidiotop
hardli
becom
suitabl
vaccin
polioviru
picornavir
genom
highli
conserv
indic
import
function
viral
replic
interestingli
infecti
recombin
edna
plasmid
obtain
molecular
cloningof
fulllengthreversetranscribedcoxsackieviru
edna
contain
ccaaaa
deviat
termin
sequenc
uuaaaa
coxsackieviru
wild
type
rna
remark
sequenc
rna
edna
gener
viru
prepar
obtain
independ
transfect
experi
ident
authent
coxsackieviru
rna
sequenc
uuaaaa
therefor
two
ump
residu
miss
infecti
recombin
coxsackieviru
edna
must
recaptur
cours
viru
replic
assum
two
ump
residu
contribut
uridylyl
virusprotein
vpgpuu
act
primer
rna
synthesi
footandmouthdiseas
viru
fmdv
proteinas
involv
posttransl
matur
viru
protein
possibl
pathogenesi
infect
cell
analysi
proteolysi
may
explain
process
molecular
level
prerequisit
simpl
proteinasespecif
assay
basic
establish
use
recombin
dna
techniqu
commun
earlier
work
result
express
clone
fmdv
cdna
includ
proteinas
gene
e
coli
activ
enzym
produc
protein
could
identifi
new
approach
proteinas
gene
fuse
staph
aureu
protein
gene
present
gene
express
result
fusion
protein
ctermin
part
specif
proteinas
ntermin
part
protein
latter
enabl
detect
express
product
affin
antibodi
experi
show
fact
protein
aspecif
polypeptid
produc
howev
reduc
molecular
weight
compar
protein
express
alon
construct
truncat
proteinas
gene
conclud
protein
substrat
enzym
convert
product
detect
substrat
enabl
one
follow
purif
activ
enzym
e
coli
serolog
diagnosi
recent
enteroviru
infect
present
seriou
problem
clinic
virolog
reliabl
serolog
method
would
great
clinic
signific
eg
myocard
type
diabet
sinc
elisatest
lack
type
specif
look
neutral
igm
antibodi
vs
six
coxsacki
cox
b
type
sera
patient
igm
separ
twostepcolumnchromatographi
test
microneutr
test
patient
igm
neg
show
igm
antibodi
vs
one
two
three
serotyp
good
correl
serum
antibodi
titer
igm
posit
incid
antibodi
vs
cox
b
type
increas
age
patient
heterotyp
rise
igm
antibodi
titer
could
demonstr
patient
cox
b
isol
conclud
neutral
antibodi
cox
b
virus
appear
persist
lifelong
heterotyp
igm
booster
occur
igm
may
persist
extend
period
time
coxsackievirus
cox
type
b
picornavirus
share
common
antigen
even
human
neutral
antibodi
exhibit
cross
reaction
tri
produc
monoclon
antibodi
mab
variou
cox
b
viru
type
found
differ
substanti
regard
immunogen
mab
cox
lack
neutral
capac
microneutr
plaqu
reduct
test
bind
mab
dot
blot
nitrocellulos
depend
antigen
prepar
obvious
bind
typespecif
intern
antigen
also
shown
western
blot
immunoblot
use
digest
cox
show
sever
band
proteas
nchlorosuccinimid
comparison
polyclon
antisera
prove
possibl
due
antibodi
proteas
competit
inhibit
bind
yield
weak
posit
result
preincub
mab
follow
incub
polyclon
typespecif
rabbit
antiserum
murin
hybridoma
produc
poliovirusspecif
monoclon
antibodi
mab
obtain
adult
balbc
mice
immun
complet
infecti
polioviru
type
mahoney
human
b
cell
line
produc
mab
reract
polioviru
type
gener
transform
epsteinbarr
viru
ebv
b
tonsillar
lymphocyt
sever
immun
donor
murin
hybridoma
ebvtransform
cell
clone
semisolid
agaros
neutral
nt
murin
mab
recogn
neutral
polioviru
type
wherea
human
ntrrtab
neutral
either
polioviru
type
three
serotyp
mab
reactiv
polioviru
type
type
detect
immunoprecipit
radiolabel
polioviru
type
crossreact
human
ntmab
inhibit
competit
preincub
mab
cold
polioviru
type
andor
rna
genom
footandmouth
diseas
viru
fmdv
express
polyprotein
rapidli
process
matur
protein
two
viral
proteas
least
one
host
cell
proteas
involv
cleavag
reaction
character
polyprotein
cleavag
site
two
viral
proteas
ill
construct
plasmid
mutat
protein
rna
deriv
plasmid
use
rna
polymeras
express
rabbit
reticulocyt
lysat
protein
identifi
differ
specif
antisera
correspond
nearli
part
polyprotein
result
process
site
found
lll
proteas
junction
l
pi
viral
proteas
seem
respons
cleavag
site
except
junction
autocatalyt
cleavag
fusion
viral
capsid
nucleoprotein
np
genesequ
four
h
influenza
aviru
strain
compar
addit
known
viru
strain
accord
sequenc
data
strain
show
remark
antigen
drift
npgene
compar
progenitor
latter
one
disappear
year
stay
yet
unknown
place
strain
chang
amino
acid
come
aspart
glutam
alanin
probabl
result
loss
abil
rescu
nptemperaturesensit
mutant
fowl
plaqu
viru
doubli
infect
chick
embryo
fibroblast
cell
npgene
last
strain
show
intermedi
homolog
sequenc
human
h
h
strain
report
influenza
infect
establish
viru
isol
patient
gener
pediatr
practic
influenza
season
difficult
differenti
influenza
acut
respiratori
infect
influenza
diagnos
virolog
method
children
nasopharyng
secret
taken
viru
isol
mdckcell
identif
influenza
viru
carri
fitc
label
specif
antibodi
idol
et
med
microbio
immuno
children
influenza
subtyp
isol
children
influenza
subtyp
children
influenza
b
case
influenza
odphas
variat
found
three
typic
manifest
observ
monophas
fever
biphas
fever
croup
relationship
influenza
type
resp
subtyp
symptom
could
establish
influenza
reach
peak
week
influenza
week
follow
influenza
b
peak
week
work
support
feder
ministri
research
technolog
zr
ebner
g
siddel
inst
f
virologi
u
immunbiologi
univ
wiirzburg
coronavirus
positivestrand
rna
virus
replic
cytoplasm
infect
cell
express
murin
corona
viru
mhv
genom
mediat
subgenom
mrna
gene
product
mrna
nucleocapsid
membran
spike
protein
virion
code
sequenc
sever
mrna
encod
nonstructur
protein
clone
sequenc
howev
correspond
gene
product
rigor
identifi
vivo
edna
copi
mhvjhm
mrna
clone
bacteri
vector
pur
express
bgalactosidas
fusion
protein
viral
encod
polypeptid
synthes
bacteria
use
rais
antibodi
rabbit
antiserum
direct
cterminu
viral
mrna
gene
product
recogn
authent
polypeptid
vivo
vitro
major
mrna
translat
product
predict
sequenc
analysi
molecular
weight
polypeptid
clone
sequenc
nucleoprotein
gene
influenza
viru
strain
south
china
gammelin
b
schroder
ch
scholtissek
lnst
f
virolog
univ
giessen
genom
influenza
virus
consist
eight
singlestrand
rna
segment
exchang
doubl
infect
sinc
avian
influenza
virus
probabl
transfer
human
be
natur
circumst
hand
human
influenza
virus
transfer
directli
bird
exchang
singl
segment
take
place
pig
doubl
infect
pig
probabl
toler
growth
avian
human
influenza
viru
strain
nucleoprotein
np
whose
phosphopeptidfingerprint
strainspecif
host
cell
depend
like
respons
speci
specif
follow
question
examin
sequenc
comparison
sequencesof
npgene
one
human
one
avian
two
porcin
influenza
viru
strain
speci
specif
differ
sequenc
npgene
adapt
np
pig
would
new
host
present
result
allow
follow
conclus
sequenc
npgene
possess
high
homolog
nlvgene
human
influenza
viru
strain
clearli
differ
sequenc
l
pgene
hornolog
nlgene
avian
influenza
viru
strain
npgene
similar
npgene
hand
npgene
swl
deriv
avian
influenza
viru
strain
show
mani
base
exchang
found
avian
strain
mean
firstli
speci
specif
differ
sequenc
npgene
secondli
npgene
deriv
avian
influenza
viru
strain
way
adapt
pig
previou
studi
strain
jo
influenza
c
viru
reveal
receptordestroy
enzym
viru
neurarnin
ovacetylesteras
acid
receptordetermin
attach
infl
uenza
c
viru
cell
extend
investig
six
strain
infl
uenza
c
viru
strain
found
contain
acerylesteras
use
bovin
submandibulari
mucin
bsm
substrat
maximum
variat
enzym
activ
differ
strain
tenfold
rat
serum
found
prevent
strain
influenza
c
viru
test
agglutin
chicken
red
blood
cell
hemagglutinationinhibit
titer
determin
differ
strain
vari
inhibitori
activ
abolish
incub
inhibitor
acetylesteras
result
conclud
receptor
determin
influenza
c
virus
ii
factor
presenc
also
affect
bind
influenza
c
virus
cell
surfac
receptor
differsfrom
wildtypeviru
sendaiz
frame
shift
mutat
posit
possibl
repres
rsrnutat
alter
cterminu
aminoacid
longer
verifi
sequencingth
ctermin
tryptic
peptideth
persist
releas
timeslessviru
acut
infectedcel
northen
blot
experi
show
mrna
viral
protein
also
strongli
reduc
tryptic
peptid
pattern
npprotein
persist
infect
slightli
differ
sendaiviru
npprotein
shown
hplcanalysi
differenttrypt
peptid
sequenc
npprotein
play
central
role
regul
viral
transcript
replic
therefor
assum
low
effici
viru
replic
due
alter
found
protein
clone
hemagglutinin
gene
fowl
plagu
viru
introduc
baculoviru
acnpv
use
homolog
recombin
techniqu
previous
biolog
activehemagglutinin
detect
cultur
insect
cell
infect
recombin
acnpv
kuroda
et
al
embo
express
hemagglutinin
whole
insect
infect
larva
tobacco
budworm
iheliothi
uirescensi
hemagglutinin
synthes
fat
bodi
epidermi
trachea
gut
indic
recombin
viru
tropism
authent
ac
jpv
hemagglutinin
correctli
process
tissu
fragment
hal
ha
hornogen
infect
larva
exhibit
hemagglutin
activ
could
use
effect
immun
chicken
fowl
plagu
mandl
ch
heidi
holzmann
f
x
heinz
ch
kur
z
inst
virolog
univ
vienna
genom
tickborn
enceph
tbe
viru
consist
positivestrand
rna
molecul
approxim
nucleotid
lack
polya
structur
cnd
tbespecif
clone
part
genom
contain
entir
sequenc
inform
structur
protein
c
prm
e
sequenc
deduc
amino
acid
sequenc
contain
characterist
stretch
hydrophob
anchor
posit
charg
stop
transfer
sequenc
signalas
proteas
cleavag
site
function
process
structur
protein
homolog
among
flaviviru
structur
protein
sequenc
found
vari
depend
protein
virus
compar
glycosyl
site
show
degre
homolog
gener
conserv
among
flavivirus
cystein
residu
howev
highli
conserv
stress
import
inter
function
protein
structur
heinrichpetteinst
f
exp
virologi
u
immunologi
univ
hamburg
studi
mechan
higher
organ
control
viru
infect
adult
mous
acut
infect
lcm
viru
valuabl
viru
replic
major
organ
yet
caus
patholog
alter
henc
termin
infect
confound
ill
monoclon
antibodi
mab
direct
lymphocyt
subset
inocul
anim
infect
effect
viru
elimin
antivir
immun
respons
determin
antithyl
mab
diminish
viru
clearanc
activ
cytotox
lymphocyt
ctl
reduc
partli
antithyi
antibodi
respons
treatment
mab
effect
viru
elimin
ctl
activ
abolish
humor
respons
conclud
control
viru
ctl
essenti
wherea
antibodi
play
relev
role
ogura
h
k
baczko
b
rima
v
ter
meulen
insr
f
virologi
u
immunbiologi
univ
wiirzburg
measl
viru
present
sspe
character
defect
one
sever
envelop
protein
wherebi
matrixprotein
mostli
affect
known
mechan
defect
produc
elev
temperatur
may
playa
role
rise
temperatur
measl
viru
infect
cell
result
immedi
inhibit
protein
synthesi
correspond
mrna
still
present
stabil
protein
significantli
alter
messeng
rna
extract
shift
produc
nucleocapsid
phospho
matrixprotein
vitro
c
data
indic
mv
matrixprotein
product
select
suppress
vivo
elev
temperatur
inabl
translat
system
interact
correctli
matrix
mrna
envelop
glycoprotein
e
alter
carbohydr
chain
repg
g
ka
l
u
z
inst
f
virologi
fb
hum
anmedizin
giessen
e
viral
envelop
non
compet
epitop
af
discern
mean
monoclon
antibodi
block
test
reveal
carboh
ydrate
side
chain
viral
glycoprotein
compet
least
one
f
epitop
b
e
detect
intramolecular
disulfid
bond
viral
envelop
cleav
viru
particl
releas
presenc
md
n
particl
devoid
complex
carbohydr
chain
infect
cell
min
puls
label
two
epitop
es
seem
locat
critic
structur
point
specif
final
conform
spike
complex
antibodi
direct
epitop
b
neutr
aliz
properti
data
confirm
earlier
find
final
structur
envelop
glycoprotein
e
acquir
upon
particl
releas
schneider
chauli
es
u
g
liebert
k
baczko
v
ter
meu
l
en
inst
f
virologi
u
immunb
iologi
univ
wiirzburg
ord
er
defin
paramet
lead
persist
measl
viru
mv
infect
cn
express
mv
specif
rna
relat
protein
investig
model
measl
viru
induc
subacut
encephalom
yeliti
lewi
rat
vivo
result
suggest
synthesi
measl
viru
h
f
prot
ein
reduc
absent
brain
anim
alreadi
week
follow
infect
viru
specif
mrna
howev
shown
present
six
structur
prot
ein
subacut
type
infect
northern
blot
analysi
situ
hybrid
strand
specif
probe
transcriptiondefect
infecti
viru
could
shown
sera
infect
mice
pid
brain
cell
infect
mice
cocultiv
uninfect
mice
brain
cell
mgb
pid
howev
viru
releas
cultur
ts
hngenproduct
find
explain
revers
transcriptionmut
establish
new
mutat
hngen
organ
furthermor
mutat
second
surfaceantigen
f
mutat
allow
cleavag
inact
fusionprotein
fa
infecti
form
fjf
cellular
proteas
ts
day
cultur
revers
hntsmutat
could
seen
result
might
implic
pressur
immunsystem
select
mutant
surfaceantigen
absenc
selectionpressur
cultur
systemth
revert
becom
domin
genom
insect
iridesc
viru
type
chilo
iridesc
viru
civ
shown
circularli
permut
termin
redund
defin
complet
gene
librari
whole
civ
dna
sequenc
kbp
establish
e
g
gene
librari
compris
complet
ecori
dna
fragment
viral
genom
physic
map
viral
genom
construct
restrict
endonucleas
apai
bamhi
ecori
ncoi
pvuii
sali
smal
sphl
although
civ
genom
linear
due
circular
permut
restrict
map
circular
defin
gene
librari
civ
dna
use
identif
structur
function
properti
viral
genom
hybrid
experi
heteroduplex
map
perform
repetit
dna
element
detect
ecori
dna
fragment
h
kbp
mu
c
kbp
mu
fine
map
region
hybrid
experi
reveal
dna
sequenc
one
flank
ecori
dna
fragment
h
mu
kbp
partial
homolog
part
dna
sequenc
ecori
dna
fragment
c
rnu
kbp
character
repetit
dna
element
nucleotid
sequenc
necessari
understand
function
activ
regulatori
role
element
dfg
project
da
earlierstudi
shown
earli
gene
function
herp
simplex
viru
hsv
involv
aberr
overrepl
chromosom
integr
dnasequ
transform
cell
subsequ
could
demonstr
circular
plasmid
vector
dna
bear
ge
nome
amplifi
transfect
nontransform
hamster
cell
upon
infect
hsv
present
studi
seri
recombin
plasmid
construct
wereassay
activ
hsv
infect
amplif
abolish
region
earli
transcript
delet
ii
iantigen
gene
dissect
iii
hairpin
structur
origin
alter
delet
late
region
effect
result
indic
concert
action
origin
iantigen
herpesvir
dna
replic
function
studi
support
deutsch
forschungsgemeinschaft
sfb
thirteen
differ
monoclon
antibodi
direct
antigen
infect
cell
nuclei
select
lmmunoblot
immunoprecipit
reveal
antibodi
belong
four
differ
recognit
group
react
major
dna
bind
protein
icp
famili
dna
bind
protein
antibodi
character
collabor
h
marsden
glasgow
protein
present
virion
cell
none
antibodi
neutral
local
antigen
nuclei
specifi
immun
electronmicroscopi
famili
associ
nucleocapsid
wherea
dna
bind
protein
show
patchi
distribut
evid
antigen
repres
infect
cell
protein
viru
constitu
genom
structur
fish
lymphocysti
diseas
viru
fldv
found
circularli
permut
termin
redund
defin
complet
gene
librari
correspond
dna
sequenc
viral
genom
kbp
establish
use
defin
gene
librari
dnadnahybrid
experi
heteroduplex
map
two
repetit
dna
element
detect
map
coordin
mu
part
ecorl
dna
fragment
b
kbp
mu
coordin
mu
ecorl
dna
fragment
kbp
nucleotid
dna
sequenc
repetit
dna
element
carri
analysi
reveal
presenc
mani
small
direct
invert
repetit
e
g
two
direct
repetit
box
tttaaaatttaaatttaa
start
nucleotid
posit
two
invert
repetit
ttaaatttaaattt
nucleotid
posit
evalu
regulatori
role
signal
correspond
dna
sequenc
repetit
dna
element
fldv
compar
known
repetit
dna
sequenc
virus
e
g
poxand
herpesvirus
furthermor
dnadna
hybrid
experi
reveal
repetit
dna
element
conserv
genom
differ
strain
type
fldv
indic
import
dna
element
viru
progeni
e
g
viru
replic
encapsid
dfg
project
da
glycoprotein
b
gb
sequenc
deriv
peripher
apathogen
hsyl
strain
ko
transfer
pathogen
hsyl
ang
strain
cotransfect
experi
clone
hsyl
ko
bam
hi
g
fragment
serv
donor
genom
dna
two
ang
variant
recipi
one
variant
term
hsyl
ang
path
express
glycoprotein
c
gc
term
spontan
gc
neg
mutant
ang
strain
syn
phenotyp
wherea
hsyl
ko
syn
report
show
syn
phenotyp
hsyl
strain
ang
path
govern
syn
locu
present
evid
absenc
gc
express
certain
genet
defin
condit
compat
syn
phenotyp
provid
evid
bam
hi
g
fragment
deriv
peripher
apathogen
hsyl
ko
strain
may
confer
apathogen
pathogen
strain
convers
experi
bam
hi
g
fragment
hsyl
ang
path
restor
pathogen
apathogen
subclon
data
could
conceiv
gb
one
determin
peripher
neurovirul
use
hybrid
diagnosi
infecti
diseas
two
major
problem
radioact
probe
detect
hybrid
format
immobil
nucleic
acid
nitrocellulos
filter
altern
biotinyl
probe
use
combin
rnicrotitr
plate
hybrid
pg
purifi
hcmydna
could
detect
comparison
filter
hybrid
probe
detect
pg
biotinyl
probe
pg
dna
selfhybrid
biotinyl
hcmyspecif
probe
gave
sensit
detect
pg
homolog
dna
use
sandwich
hybrid
microtitr
plate
hcmi
detect
supernat
infect
fibroblast
urin
reconstitut
viru
microtitr
plate
hybrid
potenti
instrument
base
analysi
togeth
nonisotop
probe
may
lead
better
accept
hybrid
clinic
laboratori
pp
major
product
transcript
unit
iel
murin
cytomegaloviru
mcmv
report
previous
pp
activ
viral
promot
tran
order
analyz
molecular
mechan
transcript
activ
studi
dnabind
capac
pp
chromatographi
extract
infect
cell
calf
thymu
dna
cellulos
show
pp
interact
dna
interact
dissoci
salt
concentr
nacl
pp
cleavag
product
pp
addit
minor
iel
protein
elut
alreadi
low
ionic
strength
pp
lack
intrins
affi
niti
dna
sinc
cellular
factor
requir
dna
bind
factor
identifi
core
histon
role
amino
acid
sequenc
homolog
ntermin
region
pp
histon
pp
interact
discuss
semliki
forest
viru
sfv
induc
cellcel
fusion
atpdepend
event
kempf
c
r
mi
chel
u
kohler
h
koblet
inst
hygien
med
microbiol
univ
bern
sfv
infect
aed
albopictu
cell
fuse
mildli
acid
ph
use
investig
cellcel
fusion
shown
polykaryon
format
correl
decreas
cellular
atp
could
block
inhibitor
oxid
phosphoryl
howev
infectedcellsin
presenceof
inhibitor
expos
short
time
ph
e
g
min
intracellular
atp
transient
recov
polykaryon
format
occur
usingmicroinject
highli
fluoresc
non
permeabl
dye
lucif
yellow
demonstr
normal
condit
infectedcel
fuse
neighbour
presenc
kcn
cellcel
fusion
could
observ
thu
conclud
sfvinduc
polykaryon
format
requir
specif
expenditur
energi
atp
use
earli
fusion
process
antigen
structur
e
glycoprotein
tickborn
enceph
tbe
viru
studi
use
panel
monoclon
antibodi
mab
epitop
identifi
differ
properti
respect
serolog
reactiv
function
activ
topolog
localis
found
cluster
three
antigen
domain
b
c
epitop
domain
denatur
sensit
low
phinduc
conform
chang
local
certain
epitop
within
domain
may
play
import
role
membran
fusion
event
cours
viru
infect
b
domain
epitop
also
highli
conformationdepend
structur
stabil
disulfid
bridg
reveal
reduct
carboxymerhyl
experi
disulfid
bridg
probabl
also
respons
proteas
resist
tertiari
structur
domain
b
pathogenesi
measl
viru
induc
central
nervou
system
cn
complic
man
subacut
scleros
panenceph
post
infecti
measl
encephalomyel
includ
develop
defect
replic
cycl
possibl
gener
autoimmun
reaction
model
subacut
measl
encephalomyel
aspect
analyz
histopatholog
abnorm
character
nondemyelin
encephalomyel
promin
mononuclear
cell
infiltr
molecular
biolog
studi
demonstr
persist
measl
viru
infect
brain
cell
viral
mrna
present
restrict
viral
gene
express
anim
cellmedi
immun
respons
specif
myelin
basic
protein
mbp
found
tcell
line
specif
mbp
isol
rat
induc
enceph
naiv
recipi
observ
indic
autoimmun
reaction
occur
associ
persist
measl
viru
cn
tissu
may
involv
pathogenesi
rat
vitro
express
coronaviru
mhvjhm
surfac
protein
pfleider
g
siddel
inst
f
virologi
u
immunbiologi
univ
wiirzburg
mhvjhm
virion
compris
larg
infecti
rna
togeth
nucleocapsid
membran
surfac
protein
surfac
protein
play
major
role
pathogenesi
viral
infect
major
target
humor
cellmedi
immun
respons
carri
fusogen
properti
determin
cell
tissu
tropism
initi
function
analysi
mhvjhm
protein
clone
sequenc
protein
gene
edna
copi
insert
pgem
vector
fulllength
cap
rna
transcript
synthes
use
polymeras
vitro
transcript
translat
reticulocyt
lysat
product
analys
immunoprecipit
protein
specif
rabbit
antiserum
antiserum
immunoprecipit
major
molecular
weight
product
expect
size
protein
system
shall
map
monoclon
antibodi
recogn
sequenti
epitop
truncat
delet
region
gene
moreov
gene
construct
confid
insert
vaccinia
viru
express
system
analysi
function
protein
domain
undertaken
vivo
surfac
glycoprotein
influenza
c
remov
virion
treatment
proteas
bromelain
isol
glycoprotein
estim
molecular
weight
dalton
calcul
molecular
weight
remain
membran
bound
portion
molecul
dalton
isol
glycoprotein
purifi
sucros
densiti
gradient
centrifug
posit
protein
trimer
band
gradient
indic
sediment
coeffic
approxim
isol
uncleav
glycoprotein
gp
mdckcell
grown
viru
bromelain
protein
cleav
two
subunit
held
togeth
disulphid
bond
estim
molecular
weight
subunit
dalton
dalton
comparison
cleav
glycoprotein
cell
grown
viru
gp
egg
grown
viru
sdspolyacrylamid
gelelectrophoresi
show
differ
migrat
two
protein
indic
cleavag
cell
grown
glycoprotein
bromelain
occur
near
natur
cleavag
site
bromelain
cleavag
site
analys
muller
h
k
h
muller
h
becht
inst
f
virologi
univ
gieien
infecti
bursal
diseas
viru
caus
agent
sever
diseas
chicken
main
featur
infect
destruct
bursa
fabriciu
bf
turkey
isol
pathogen
chicken
hardli
crossreact
neutral
test
chicken
isol
st
turkey
isol
st
besid
differ
size
two
rnaseg
differ
protein
pattern
reassort
produc
doubl
infect
st
st
larger
segment
reassort
deriv
chicken
strain
smaller
one
code
virionassoci
polymeras
turkey
strain
reassort
caus
clinic
sign
altough
mani
bursal
cell
infect
bursal
follicl
total
destroy
therefor
pathogen
properti
ibdv
depend
partli
smaller
segment
code
rnapolymeras
could
shown
westernblot
analysi
increas
number
epitop
differ
protein
band
detect
first
week
onset
primari
cytomegaloviru
hcmv
infect
sever
week
antibodi
numer
protein
band
complet
viru
particl
could
demonstr
transplant
recipi
reactiv
addit
band
broaden
protein
band
observ
result
observ
inhibit
test
develop
arch
viro
use
differenti
primari
infect
reactiv
testprincip
might
improv
polyclon
human
antibodi
tracer
could
substitut
monoclon
antibodi
direct
late
epitop
order
detect
late
epitop
proteinpattern
obtain
sera
primari
cytomegaloviru
infect
reactiv
compar
immunoblot
studi
could
conclud
weak
epitop
could
found
preferenti
protein
epitop
detect
sera
person
repeat
immunis
reactiv
human
cytomegaloviru
hcmv
particl
contain
phosphoprotein
pp
molecular
weight
matrix
protein
predomin
structur
constitu
hcmv
particl
mainli
found
dens
bodi
lytic
infect
cell
recent
clinic
isol
hcmv
necessarili
pp
abund
compon
neither
low
passag
wildtyp
virus
appreci
amount
dens
bodi
humor
immun
respons
infect
individu
pp
variabl
alway
detect
western
blot
analys
reactiv
correl
clinic
statu
howev
correl
titr
complement
fixat
test
rais
antibodi
hcmv
phosphoprotein
rabbit
gene
map
corrobor
rel
immunogen
properti
hcmv
protein
immun
dens
bodiesor
gelpurifi
result
rapid
seroconvers
taken
togeth
experi
show
pp
immunogen
weak
antibodi
respons
cours
natur
infect
probabl
due
low
amount
pp
wildtyp
virion
genom
organ
gene
code
pp
recent
describ
detail
b
ruger
et
ai
j
virol
sever
differ
splice
mrna
transcrib
transcript
unit
iel
mcmv
abund
mrna
code
major
iel
protein
pp
pho
sphoprotein
transport
nucleu
abl
tr
ansactiv
gene
unknown
iel
product
recogn
ctl
associ
mhc
class
gene
product
transfect
iel
l
cell
still
remain
unresolv
whether
major
iel
prote
pp
product
one
minor
iel
rna
speci
respon
sibl
target
format
order
integr
open
read
frame
orf
vaccinia
intron
interrupt
orf
remov
sitedirect
mut
agenesi
clone
express
vector
pg
orf
brought
control
vaccinia
promot
homolog
recombin
orf
subsequ
entli
integr
vaccinia
irnmunopr
ecipit
reveal
expr
ession
process
product
cell
infect
orf
recombin
nuclear
local
confirm
indirect
immunofluoresc
clone
line
iespecif
ctl
recogn
orf
infect
target
cell
therefor
conclus
evid
could
obt
ain
regulatori
nonstructur
herp
viral
prot
ein
give
rise
membran
antigen
detect
ctl
system
nonpmlpati
dorri
kristina
inst
f
virolog
u
immunbiologi
univ
wiirzburg
primari
lcv
infect
lead
lifelong
persist
men
rare
case
lytic
infect
glia
cell
result
pml
prob
abli
consequ
late
reactiv
persist
cn
infect
would
requir
presenc
lcv
nonpml
brain
search
evid
lcv
dna
examin
brain
materi
individu
sever
system
neurolog
disord
other
pml
molecular
hybrid
techniqu
although
concentr
ation
viru
sequenc
low
jcv
supercoil
dna
could
detect
correspond
length
lcv
genom
isol
pml
patient
electroelut
cellular
dna
hybrid
complet
bamhiipvuii
restrict
pattern
lcv
strain
gs
thu
show
presenc
l
cv
genom
cn
individu
pml
dat
support
idea
reactiv
persist
lcv
infect
may
contribut
significantli
pathogenesi
pml
podlech
potratz
preuh
muller
falk
div
expo
virolog
inst
med
microbiol
univ
mainz
recent
describ
replic
strain
adren
mice
independantli
degre
neuropathogen
arch
virol
therefor
postul
two
type
tropism
moreov
corticoid
hormon
level
increas
serum
strain
howev
replic
less
well
adren
strain
lack
replic
complet
succeed
isol
variant
strain
er
one
replic
well
low
degre
adren
therefor
third
type
tropism
emerg
variant
isol
sever
passag
along
adren
plaqu
purifi
line
stabl
test
properti
replic
macrophag
verocel
corticoid
cell
type
cpe
replic
ovariesand
uteru
determin
p
c
ldso
protein
label
dna
cut
analyz
agaros
gel
strong
replic
ovari
uteru
seem
correl
higher
suscept
femal
mice
hsv
strain
hfem
apathogen
tree
shrew
mice
intraperiton
ip
rout
due
delet
genom
coordin
insert
bamhi
dna
fragment
b
mu
mlui
dna
fragment
coordin
molecularli
clone
virul
strain
f
restor
ip
pathogen
strain
hfem
stabl
intratyp
recombin
viru
establish
virul
anim
indic
viral
dna
sequenc
involv
ip
pathogen
locat
within
genom
coordin
determin
nucleotid
sequenc
flank
delet
genom
avirul
hfem
correspond
region
genom
virul
recombin
viru
carri
compar
dna
sequenc
virul
wild
type
hsvl
analysi
reveal
presenc
open
read
frame
orf
region
function
activ
seem
involv
viral
pathogen
correspond
dna
sequenc
recogn
differ
cellular
element
control
develop
infect
tree
shrew
mous
dfg
project
da
adv
autonom
parvoviru
consist
two
structur
protein
kd
addit
viru
prepar
polypeptid
kd
detect
furthermor
nonstructur
protein
kd
encod
viral
dna
analys
protein
isol
western
blot
techniqu
monoclon
antibodi
specif
structur
protein
recogn
could
detect
two
differ
antibodi
analyz
epitop
antigen
relationship
viral
protein
polypeptid
subject
chemic
enzymat
cleavag
subject
epitop
map
monoclon
antibodi
close
antigen
relationship
structur
protein
demonstr
howev
structur
nonstructur
protein
reveal
common
epitop
